News & Events
Interim AHSCT trial results released
Interim results from one of the first randomised controlled trials comparing autologous haematopoietic stem cell transplant (AHSCT) to other…
Siponimod offers hope for people with secondary progressive MS
A new, international clinical trial has shown that siponimod can slow progression in people with secondary progressive…
Uruguay – Project Planning and Fundraising Consultancy Opportunity
MSIF is seeking experienced Spanish-speaking consultants, preferably based in Uruguay, to provide training and mentoring in the…
UK MS Society volunteers raise awareness of MS at international event
Volunteers from the UK MS Society’s English Council worked with the Rotarian Action Group for MS Awareness…
Polish MS Association launches MS peer support programme
The ‘Peer to Peer’ support programme is designed to support people with MS shortly after diagnosis.
US launches ‘Whatever it Takes’ campaign for MS Awareness Week
The National MS Society launched a new awareness-raising campaign during the US MS Awareness Week 2018, engaging…
Special guests to attend MSIF’s Global Networking Meetings in Amsterdam
Queen Maxima of the Netherlands and two Olympic speed skaters will join delegates.
Tawasol – March 2018 issue
The latest news from the Multiple Sclerosis (MS) associations in the Arab region.
Japanese study could improve understanding of autoimmune process in MS
New research indicates that miRNA, a genetic switch in the blood of people with MS, could help…
Experimental immunotherapy shows promising trial results
A new immunotherapy that re-educates the immune system has shown promising results in two early-stage clinical trials.
Difference in immune molecule may explain gender divide in MS
A new study identifies some key differences between the immune system of men and women, which may…
Sun exposure can alter risk and disease course in early MS
New research shows that sun exposure over a lifetime can change the course of MS.